InMed Pharmaceuticals (INM) Q4 2024 Earnings

15NovConfirmed
Q3 2023
Q4 2023
Q2 2024
Q4 2024
-2.71
-1.87
-1.02
-0.18

Details

Expected EPS
N/A
Actual EPS
-2.71
Surprise EPS
-2.71
Surprise Percent
+∞%

Description

InMed Pharmaceuticals (INM) has reported earnings of -2.71 per share for Q4 2024.

0 Comments

Share your thoughts